Introduction
Schizophrenia (SZ) is a severe brain disorder characterized by positive symptoms (e.g., delusions and hallucinations), negative symptoms (e.g., affective flattening, apathy, and social withdrawal), and cognitive dysfunction. The disease typically affects adolescents and young adults, and the majority of the cases have a chronic course, resulting in abnormal mental functions and significant social disability (Sawa and Snyder, 2002; Thaker and Carpenter, 2001) . Despite considerable research, neither the etiology nor pathogenesis that underlies such functional deficits is yet fully understood.
The relevance of the olfactory system in the study of the pathophysiology of SZ is underscored by several reports that patients with SZ exhibit significant deficits in olfactory function, including odor identification (Stedman and Clair, 1998), detection threshold sensitivity (Turetsky and Moberg, 2009), discrimination (Dunn and Weller, 1989) , and memory (Wu et al., 1993) . Among such olfactory dysfunctions, deficits in odor identification have been most frequently described in SZ (Cascella et al., 2007) . Studies with use of the University of Pennsylvania Smell Identification Test (UPSIT) (Doty et al., 1984) , show that up to 80% of SZ patients have deficits in odor identification, whereas less than 15% of the general population show such deficits (Moberg et al., 1999) . These deficits are seen early in the course of the illness and appear to be correlated with the duration of the disorder, although independent of normal aging effects (Kopala et al., 1995) . The impact of possible confounding variables, such as gender, medication, or smoking history, has also not been significant (Brewer et al., 2001; Corcoran et al., 2005; Malaspina and Coleman, 2003; Moberg et al., 1999 Moberg et al., , 2006 Roalf et al., 2006; Rupp et al., 2005a,b Deficits in odor identification have been most frequently described in schizophrenia (SZ). A relationship between dysfunction in odor identification and negative symptoms of SZ has also been reported. Furthermore, deficit SZ (a subtype of the illness with primary, enduring negative symptoms) has been found to be associated with a particularly poor performance on odor identification tests indicating that deficits in smell identification could be differentially expressed in some subtypes of SZ. We describe correlations of performance on smell identification with positive and negative symptoms of SZ. Patients with SZ (n = 15) and normal controls (n = 19) were tested by the University of Pennsylvania Smell Identification Test (UPSIT). Psychopathology was assessed with the Scales for the Assessment of Positive and Negative Symptoms (SAPS and SANS). SZ patients performed more poorly on the UPSIT test than did normal controls. Consistent with previous findings, we observed a correlation of SANS with UPSIT performance. In particular, specific subdomains of SANS, such as blunted affect, apathy and anhedonia, were associated with odor identification deficits. Furthermore, UPSIT score predicts these subdomains of negative symptoms. No correlation was observed between positive symptom and odor identification deficits. Our study further reinforces a relation between olfactory identification deficit and negative symptoms in SZ and suggests that smell identification could be a candidate endophenotype relevant to negative symptoms of SZ.
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